First-line IVF produced more live births than IUI within 7 months in couples with unexplained infertility.
|Articles|February 1, 2012
War Savings May Be Key To Long-Term 'Doc Fix' Deal
Advertisement
The congressional conference committee is trying to hammer out a bargain on a payroll tax cut extension and the Medicare "doc fix." If the conferees — who are now discussing the possibility of a permanent "doc fix" — fail to agree to a proposal, doctors who see Medicare patients are in line for a 27% cut slated to take effect in March.
Kaiser Health News covered the meeting. The audio interview and transcript are available here:
Advertisement
Related to this article
Elafibranor and seladelpar normalized ALP in most patients with primary biliary cholangitis whose ALP was below the usual escalation threshold.
The FDA granted accelerated approval to amivantamab and hyaluronidase for previously treated recurrent or metastatic head and neck cancer.
Most patients with MASH stay on resmetirom at 1 year, but Medicaid coverage was tied to lower odds of filling a first prescription within 30 days.
A 20-year review traces how immune checkpoint inhibitors became a cornerstone of lung cancer treatment.
David T. Plante, MD, PhD, explains that separating mood-related sleepiness from primary hypersomnia relies on the course of illness and sleep testing.
Phase 3 Viti-Up trials show Rinvoq (upadacitinib) JAK inhibitor boosts facial and body repigmentation in nonsegmental vitiligo, with familiar safety.
A population-based study of 1102 Canadian children found infants with bone and soft tissue tumors had poorer survival, driven largely by treatment deaths.
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Meets CV Safety End Point in SYNCHRONIZE-CVOT
2
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
3
Pharmacy, Claims Data Show High Resmetirom Persistence in MASH
4
Phase 3 Data Back ALP Normalization as Treatment Goal in PBC
5